Surgical Site Infection Clinical Trial
Official title:
Prevention of Surgical Site Infections in Total Joint Arthroplasty: Iodine Impregnated Adhesive Drapes Versus Cyanoacrylate-Based Sealant
Infection after total joint arthroplasty can have devastating consequences. Adhesive drapes have been traditionally used at our institution to help reduce the risk of wound contamination and infection by superficial skin flora. Our primary objective is to determine if a cyanoacrylate-based sealant (FloraSeal microbial sealant) is superior to conventional iodine impregnated drapes in prevention of both superficial and deep surgical site infections in total joint arthroplasty (TJA) patients. A prospective, randomized controlled model will be used to answer this question.
Demand for Total Knee Arthroplasty (TKA) and Total Hip Arthroplasty (THA) is increasing
steadily and is projected to continue trending upwards in the coming years. Postoperative
infections are a common but also potentially devastating complication of total joint
arthroplasty.
Various strategies are employed both pre-operatively and post-operatively to prevent this
complication. A 2011 Cochrane Review concluded that Iodine impregnated adhesive drapes had no
impact on surgical site infection rate when used in various surgical procedures not specific
to orthopaedics. The recent SSI prevention guidelines by the World Health Organization did
not find any evidence to support the use of adhesive drapes during surgery and recommends
against its use.
Currently, iodine impregnated adhesive drapes in conjunction with either chorahexadine
gluconate or Iodine Povacrylex and Isopropyl Alcohol are the standard of care at our
institution.
FloraSeal is a cyanoacrylate-based sealant. A cyanoacrylate microbial sealant minimizes
endogenous bacteria spread to the surgical site by forming a sterile film bonded onto a
patient's skin. This film, which is formed upon polymerization, prevents the spread of
microorganisms. The protective mechanism is mechanical: the film traps and immobilizes
microorganisms that survive on a patient's skin. It has been previously shown to effectively
immobilize both gram positive and gram negative bacteria. Additionally, the sealant itself
can effectively reduce the superficial bacterial burden on the skin surface and also helps
reduce skin moisture buildup on skin.
Furthermore, with conventional adhesive drapes, the edges must be peeled back at the time of
skin closure in order to effectively close the surgical site. It is at this moment that the
incision becomes most vulnerable to penetration by local microorganisms. FloraSeal and other
cyanoacrylate based sealants remain on the skin for 5 to 10 days until the superficial skin
sloughs off.
Studies on sterile pig skin demonstrated FloraSeal to be more effective alone at immobilizing
bacteria than incisional drapes. The efficacy was the same when FloraSeal was used with or
without the incisional drapes, demonstrating that it may be used as a substitute.
Additionally, a 2013 retrospective study in revision shoulder arthroplasty demonstrated a
potential reduction in positive intraoperative deep tissue cultures when using a
cyanoacrylate-based microbial sealant versus the iodine impregnated incisional drapes. The
study lacked sufficient power to reach significance, calling for further investigation of
this effect.
Cyanoacrylate has been investigated in other surgical interventions. A 2008 prospective,
randomized multicenter clinical trial in patients undergoing elective open hernia repair
demonstrated cyanoacrylate-based microbial sealant independently reduced wound contamination
over the course of the operation.
Due to the potentially devastating complications associated with postoperative infection, the
investigators seek to find alternative methods of prevention of surgical site infection.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04096885 -
The Inselspital Surgical Cohort Study
|
||
Terminated |
NCT03820648 -
Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy
|
N/A | |
Completed |
NCT04067843 -
Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study
|
N/A | |
Terminated |
NCT04042077 -
Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections
|
Phase 3 | |
Completed |
NCT05841576 -
Anaesthetic Management Guided by COMET Measurements
|
N/A | |
Withdrawn |
NCT05338281 -
NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT
|
N/A | |
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Completed |
NCT01697748 -
Prospective Study on Cesarean Wound Outcomes
|
N/A | |
Terminated |
NCT01789697 -
Text Message Study
|
N/A | |
Recruiting |
NCT05966961 -
Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
|
||
Recruiting |
NCT05077592 -
Addition of Pre-wound Closure Povidone Iodine Wash Versus Direct Wound Closure Effect on Surgical Site Infections
|
Phase 4 | |
Recruiting |
NCT05502380 -
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
|
Phase 3 | |
Recruiting |
NCT05763602 -
PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)
|
Phase 4 | |
Recruiting |
NCT03221023 -
Intrawound Vancomycin Prophylaxis for Neural Stimulator
|
Phase 2/Phase 3 | |
Completed |
NCT03257202 -
Topical Treatment and Prevalence of P. Acnes
|
Phase 2 | |
Completed |
NCT06154720 -
Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
|
||
Not yet recruiting |
NCT06465901 -
A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI
|
N/A | |
Not yet recruiting |
NCT04820075 -
Efficacy of an Intervention to Improve the Preoperative Shower in Scheduled Surgery
|
N/A | |
Recruiting |
NCT03561376 -
Zinc Oxide Versus Petrolatum Following Skin Surgery
|
Early Phase 1 | |
Not yet recruiting |
NCT04496180 -
Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy
|
N/A |